Get the Stockscreener App
0.8204
1.08%
0.0088
After Hours:
.81
-0.0104
-1.27%
Pasithea Therapeutics Corp stock is traded at $0.8204, with a volume of 76,147.
It is up +1.08% in the last 24 hours and up +6.50% over the past month.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
See More
Previous Close:
$0.8116
Open:
$0.806201
24h Volume:
76,147
Relative Volume:
0.64
Market Cap:
$6.11M
Revenue:
-
Net Income/Loss:
$-16.28M
P/E Ratio:
-0.059
EPS:
-13.91
Net Cash Flow:
$-13.75M
1W Performance:
+6.61%
1M Performance:
+6.50%
6M Performance:
-31.06%
1Y Performance:
-82.58%
1-Day Range:
$0.8009
$0.83
1-Week Range:
$0.75
$0.84
52-Week Range:
$0.65
$5.00
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
Name
Pasithea Therapeutics Corp
Sector
Industry
Phone
(702) 514-4174
Address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
Compare KTTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.8204 | 6.04M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pasithea Therapeutics Corp Stock (KTTA) Latest News
Pasithea Therapeutics Corp Equity Warrant Stock Analysis and ForecastFederal Reserve Announcements & Get Tomorrow’s Winners Today With AI - earlytimes.in
What recovery options are there for Pasithea Therapeutics Corp.Product Launch & Free Community Supported Trade Ideas - newser.com
Is a relief rally coming for Pasithea Therapeutics Corp. Equity Warrant holdersJuly 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com
Real time breakdown of Pasithea Therapeutics Corp. stock performanceMarket Risk Analysis & High Conviction Investment Ideas - newser.com
What risks investors should watch in Pasithea Therapeutics Corp. stockMarket Risk Analysis & Fast Moving Trade Plans - newser.com
Pasithea Therapeutics Corp. stock daily chart insights2025 Short Interest & Daily Risk Controlled Trade Plans - newser.com
Will Pasithea Therapeutics Corp. stock maintain dividend yield2025 Trading Recap & Long Hold Capital Preservation Tips - newser.com
Is it time to cut losses on Pasithea Therapeutics Corp.July 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Using R and stats models for Pasithea Therapeutics Corp. forecasting2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
How Pasithea Therapeutics Corp. stock responds to policy changesJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Can technical indicators confirm Pasithea Therapeutics Corp. Equity Warrant’s reversalJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Trend analysis for Pasithea Therapeutics Corp. this weekWall Street Watch & Weekly Top Stock Performers List - newser.com
What Makes Three M Paper Boards Limited Stand Out Among CompetitorsVolume Weighted Average Price & Maximum Profit Growth - earlytimes.in
Using Bollinger Bands to evaluate Pasithea Therapeutics Corp.2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Tick level data insight on Pasithea Therapeutics Corp. volatilityGDP Growth & Verified Trade Idea Suggestions - newser.com
Can trapped investors hope for a rebound in Pasithea Therapeutics Corp. Equity Warrant2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com
Pasithea Therapeutics Corp. stock trendline breakdownWeekly Earnings Recap & Verified Momentum Stock Alerts - newser.com
Pasithea Therapeutics (NASDAQ:KTTA) Shares Up 2.5% – Here’s Why - Defense World
How currency fluctuations impact Pasithea Therapeutics Corp. stock2025 Major Catalysts & Accurate Technical Buy Alerts - newser.com
What to expect from Pasithea Therapeutics Corp. in the next 30 days2025 Biggest Moves & Verified Entry Point Signals - newser.com
Can Pasithea Therapeutics Corp. stock rebound after recent weakness - newser.com
Pasithea Therapeutics Corp Stock (KTTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pasithea Therapeutics Corp Stock (KTTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
2.05%
4.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):